Back to GetFilings.com



Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q

þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended March 31, 2005
 
 
¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period From _____ to _____

COMMISSION FILE NUMBER 0-24765

hi/fn, inc.
(Exact Name of Registrant as specified in its Charter)

Delaware 33-0732700
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)

750 University Avenue, Los Gatos, California 95032
(Address of principal executive offices and Zip Code)

Registrant’s telephone number, including area code: (408) 399-3500

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

YES  þ NO  ¨

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).

YES  þ NO  ¨

The number of shares outstanding of the Registrant’s Common Stock, par value $.001 per share, was 14,089,284 at April 25, 2005.


TABLE OF CONTENTS

PART I. FINANCIAL INFORMATION
Item 1. Financial Statements (unaudited)
Condensed Consolidated Balance Sheets
Condensed Consolidated Statements of Operations
Condensed Consolidated Statements of Cash Flows
Notes to Condensed Consolidated Financial Statements
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Quantitative and Qualitative Disclosure About Market Risks
Item 4. Controls and Procedures
PART II. OTHER INFORMATION
Item 4. Submission of matters to a Vote of Security Holders
Item 5. Other Information
Item 6. Exhibits and Reports on Form 8-K
Signatures
Index to Exhibits
Exhibit 31.1
Exhibit 31.2
Exhibit 32.1
Exhibit 32.2

Table of Contents

HIFN, INC.

INDEX TO FORM 10-Q

PART I. FINANCIAL INFORMATION
  Item 1. Financial Statements (unaudited)
Condensed Consolidated Balance Sheets as of March 31, 2005 and September 30, 2004 3
Condensed Consolidated Statements of Operations for the three and six months ended
   March 31, 2005 and 2004
4
Condensed Consolidated Statements of Cash Flows for the six months ended
   March 31, 2005 and 2004
5
Notes to Condensed Consolidated Financial Statements 6 - 10
  Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 11 - 30
  Item 3. Quantitative and Qualitative Disclosure About Market Risks 31
  Item 4. Controls and Procedures 31
PART II. OTHER INFORMATION 32
  Item 4. Submission of Matters to a Vote of Security Holders 32
  Item 5. Other Information 33
  Item 6. Exhibits and Reports on From 8-K 33
Signatures 34
Index to Exhibits

-2-


Table of Contents

   PART 1 – FINANCIAL INFORMATION

   Item 1. Financial Statements

HIFN, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)
(unaudited)

March 31,
2005

September 30,
2004

ASSETS
CURRENT ASSETS:  
 Cash and cash equivalents   $ 29,475   $ 16,816  
 Short-term investments    21,958    33,216  
 Accounts receivable, net    6,529    5,653  
 Inventories    1,891    2,051  
 Prepaid expenses and other current assets    1,260    988  


    Total current assets    61,113    58,724  
Property and equipment, net    1,813    1,737  
Intangible assets, net    11,682    13,338  
Other assets    2,184    2,443  


    $ 76,792   $ 76,242  


LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES:  
 Accounts payable   $ 4,593   $ 4,323  
 Accrued expenses and other current liabilities    8,086    7,690  


    Total current liabilities    12,679    12,013  


STOCKHOLDERS' EQUITY:  
 Common stock    14    14  
 Additional paid-in capital    162,822    161,500  
 Accumulated other comprehensive loss    (58 )  (50 )
 Accumulated deficit    (98,665 )  (97,235 )


       Total stockholders' equity    64,113    64,229  


    $ 76,792   $ 76,242  


        See accompanying notes to condensed consolidated financial statements.

-3-


Table of Contents

HIFN, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)
(unaudited)

Three Months Ended
March 31,

Six Months Ended
March 31,

2005
2004
2005
2004
Net revenues                    
   Processors   $ 11,974   $ 8,564   $ 23,153   $ 13,286  
   Software licenses and other    1,091    1,809    2,442    4,224  




      Total net revenues    13,065    10,373    25,595    17,510  




Costs and operating expenses:
   Cost of revenues - processors    4,159    2,753    7,976    4,103  
   Cost of revenues - software licenses and other    138    120    276    240  
   Research and development    5,294    5,681    10,708    10,370  
   Sales and marketing    2,184    1,943    4,103    3,631  
   General and administrative    1,579    1,228    2,756    2,221  
   Amortization of intangible assets    828    1,318    1,656    1,469  
   Purchased in-process research and development    -    -    -    3,337  




      Total costs and operating expenses    14,182    13,043    27,475    25,371  




Loss from operations    (1,117 )  (2,670 )  (1,880 )  (7,861 )
Interest and other income, net    267    109    456    211  




Loss before income taxes    (850 )  (2,561 )  (1,424 )  (7,650 )
Provision for income taxes    4    -    6    -  




Net loss   $ (854 ) $ (2,561 ) $ (1,430 ) $ (7,650 )




Net loss per share, basic and diluted   $ (0.06 ) $(0.20 ) $ (0.10 ) $ (0.63 )




Weighted average shares outstanding, basic and diluted    14,052    12,892    14,010    12,141  




        See accompanying notes to condensed consolidated financial statements.

-4-


Table of Contents

HIFN, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)
(unaudited)

Six Months Ended
March 31,

2005
2004
Cash flows from operating activities:            
     Net loss   $ (1,430 ) $ (7,650 )
     Adjustments to reconcile net loss to
     net cash provided by (used in) operating activities:
       Depreciation    477    670  
       Amortization of intangible assets    1,656    1,469  
       Amortization of deferred stock compensation    -    87  
       Loss on disposal of fixed assets    -    175  
       Purchased in-process research and development    -    3,337  
     Changes in assets and liabilities:
       Accounts receivable    (876 )  (1,365 )
       Inventories    160    (734 )
       Prepaid expenses and other current assets    (272 )  (831 )
       Other assets    259    433  
       Accounts payable    622    500  
       Accrued expenses and other current liabilities    396    (2,149 )


         Net cash provided by (used in) operating activities    992    (6,058 )


Cash flows from investing activities:
     Purchase of certain assets and intellectual property    -    (15,755 )
     Sales (purchases) of short-term investments, net    11,250    (29,401 )
     Purchases of property and equipment    (553 )  (347 )


         Net cash provided by (used in) investing activities    10,697    (45,503 )


Cash flows from financing activities:  
     Proceeds from private placement financing, net    -    30,980  
     Proceeds from issuance of common stock    1,322    2,431  
     Installment payments on acquired software licenses    (352 )  -  


         Net cash provided by financing activities    970    33,411  


Net increase (decrease) in cash and cash equivalents    12,659    (18,150 )
Cash and cash equivalents at beginning of period    16,816    41,080  


Cash and cash equivalents at end of period   $ 29,475   $ 22,930  


        See accompanying notes to condensed consolidated financial statements.

-5-


Table of Contents

HIFN, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

Note 1 — Basis of Presentation

        The condensed consolidated financial statements of hi/fn, inc. (“Hifn” or the “Company”) include the accounts of the Company and its wholly-owned subsidiaries, Hifn Limited, Hifn Netherlands B.V. and Hifn International, and its wholly-owned subsidiary, Saian Microsystems, Inc. All significant intercompany accounts and transactions have been eliminated. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

        The accompanying condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission regarding interim financial reporting. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements and should be read in conjunction with the Financial Statements and notes thereto included in the Company’s Form 10-K for period ending September 30, 2004. In the opinion of management, the accompanying condensed consolidated financial statements contain all adjustments, consisting only of normal recurring adjustments, which the Company believes are necessary for a fair presentation of the Company’s financial position as of March 31, 2005 and its results of operations for the three and six months ended March 31, 2005 and 2004, respectively. These condensed consolidated financial statements are not necessarily indicative of the results to be expected for the entire year.

        The Company anticipates that its existing cash, cash equivalents as well as short-term investments will fund any anticipated operating losses and purchases of capital equipment as well as provide adequate working capital for the next twelve months. The Company’s liquidity is affected by many factors including, among others, the extent to which the Company pursues additional capital expenditures, the level of the Company’s product development efforts, the risk of acceptance and pricing of the Company’s products and other factors related to the uncertainties of the industry and general economic conditions. Accordingly, there can be no assurance that events in the future will not require the Company to seek additional capital sooner or, if so required, that such capital will be available on terms acceptable to the Company.

        On February 6, 2004, the Company entered into a securities purchase agreement with certain investors for the private placement of 2.2 million shares of the Company’s Common Stock at a price of $15.00 per share for aggregate proceeds of $30.9 million, net of expenses of approximately $2.1 million. The shares were issued and paid for on February 6, 2004. The Company intends to apply the net proceeds for working capital and general corporate purposes, as well as for strategic purposes in connection with selected acquisitions that may be considered in the future to expand its product and service offerings. On April 9, 2004, the Registration Statement related to the private placement was declared effective by the Securities and Exchange Commission.

Note 2 — Stock Options

        The Company uses the intrinsic value method of Accounting Principles Board Opinion No. 25, “Accounting for Stock Issued to Employees,” in accounting for its employee stock options, and presents disclosure of pro forma information required under Statement of Financial Accounting Standards Board (“FASB”) Statement No. 123, “Accounting for Stock-Based Compensation” as amended by FASB Statement No. 148, “Accounting for Stock-Based Compensation — Transition and Disclosure — an amendment of FASB Statement No. 123.”

-6-


Table of Contents

        Had compensation expense for the Company’s stock-based compensation plans been determined based on the fair value method, the Company’s net loss and net loss per share would have been as follows:

Three Months Ended
March 31,

Six Months Ended
March 31,

2005
2004
2005
2004
(in thousands, except per share data)
Net loss:                        
  As reported     $ (854 ) $ (2,561 ) $ (1,430 ) $ (7,650 )
    Add: stock-based employee compensation
      recorded in the Statement of Operations   -   87   -   223  
    Less: fair value of stock-based  
      employee compensation   (1,010)  (2,054 ) (2,396)  (4,330 )




  Pro forma   $(1,864) $ (4,528 ) $(3,826) $ (11,757 )




Net loss per share:
    Basic and diluted
      As reported   $(0.06) $ (0.20 ) $(0.10) $ (0.63 )
      Pro forma   (0.13)  (0.35 ) (0.27)  (0.97 )

        The fair value of each stock option is estimated on the date of grant using the Black-Scholes model with the following assumptions used for grants during the respective periods:

Three Months Ended
March 31,

Six Months Ended
March 31,

2005
2004
2005
2004
Estimated option life 2.86 years 4.0 years 2.86 years 4.0 years
Risk-free interest rate 3.75% 2.66% 3.50% 2.78%
Expected volatility 56.3% 81.3% 57.1% 87.5%
Expected dividend yield 0.00% 0.00% 0.00% 0.00%
Weighted average estimated fair value $3.77 $8.87 $3.73 $7.49

Note 3 — Net Loss Per Share

        Basic earnings per share is computed using the weighted average number of common shares outstanding for the period, without consideration for the dilutive impact of potential common shares that were outstanding during the period. Diluted earnings per share is computed using the weighted average number of common and common equivalent shares outstanding for the period. Common equivalent shares consist of incremental common shares issuable upon the exercise of stock options, using the treasury method, and are excluded from the calculation of diluted net loss per share if anti-dilutive. Outstanding options to purchase shares of common stock and their weighted shares equivalents excluded from the computation of diluted earnings because of their anti-dilutive impact were as follows:

Three Months Ended
March 31,

Six Months Ended
March 31,

2005
2004